Literature DB >> 35373133

Left Atrial Appendage Closure: An Alternative to Anticoagulation for Stroke Prevention in Patients with Kidney Disease.

Srikanth Vallurupalli1,2, Tanya Sharma1, Subhi Al'Aref1, Subodh R Devabhaktuni1, Gaurav Dhar1,2.   

Abstract

Anticoagulation to reduce thromboembolic stroke risk due to nonvalvular atrial fibrillation in ESKD is associated with increased bleeding. There is an existing debate in ESKD centers around the pros and cons of anticoagulation. We propose percutaneous left atrial appendage occlusion as a third alternative to balance thrombosis and bleeding risks in this high-risk population.
Copyright © 2022 by the American Society of Nephrology.

Entities:  

Keywords:  anticoagulants; atrial fibrillation; blood coagulation; chronic kidney disease; left atrial appendage occlusion; stroke

Mesh：

Substances：

Year:  2021        PMID： 35373133      PMCID： PMC8967650          DOI： 10.34067/KID.0004082021

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


  27 in total

1.  Stroke and bleeding in atrial fibrillation with chronic kidney disease.

Authors:  Jonas Bjerring Olesen; Gregory Y H Lip; Anne-Lise Kamper; Kristine Hommel; Lars Køber; Deirdre A Lane; Jesper Lindhardsen; Gunnar Hilmar Gislason; Christian Torp-Pedersen
Journal:  N Engl J Med       Date:  2012-08-16       Impact factor: 91.245

2.  Implant success and safety of left atrial appendage occlusion in end stage renal disease patients: Peri-procedural outcomes from an Italian dialysis population.

Authors:  Simonetta Genovesi; Giorgio Slaviero; Luca Porcu; Gavino Casu; Silvio Bertoli; Antonio Sagone; Federico Pieruzzi; Giovanni Rovaris; Monique Buskermolen; Paolo Danna; Alberto Montoli; Jacopo Oreglia; Gina Contaldo; Patrizio Mazzone
Journal:  Int J Cardiol       Date:  2018-07-01       Impact factor: 4.164

3.  Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.

Authors:  Anders Nissen Bonde; Gregory Y H Lip; Anne-Lise Kamper; Peter Riis Hansen; Morten Lamberts; Kristine Hommel; Morten Lock Hansen; Gunnar Hilmar Gislason; Christian Torp-Pedersen; Jonas Bjerring Olesen
Journal:  J Am Coll Cardiol       Date:  2014-12-16       Impact factor: 24.094

4.  [Monocentric experience of left atrial appendage occlusion among patients with advanced chronic kidney disease and non-valvular atrial fibrillation].

Authors:  Massimo Manes; Elisabetta Radin; Valentina Pellù; Emanuele Parodi; Donatella Caputo; Danila Gabrielli; Andrea Molino; Giuseppe Paternoster; Elisa Pelloni; Francesco Pisano
Journal:  G Ital Nefrol       Date:  2020-02-12

5.  Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes.

Authors:  Elaine M Hylek; Claes Held; John H Alexander; Renato D Lopes; Raffaele De Caterina; Daniel M Wojdyla; Kurt Huber; Petr Jansky; Philippe Gabriel Steg; Michael Hanna; Laine Thomas; Lars Wallentin; Christopher B Granger
Journal:  J Am Coll Cardiol       Date:  2014-03-19       Impact factor: 24.094

6.  Impact of chronic kidney disease on Watchman implantation: experience with 300 consecutive left atrial appendage closures at a single center.

Authors:  Xin Xue; Lisheng Jiang; Erich Duenninger; Manuela Muenzel; Shaofeng Guan; Adam Fazakas; Fanzhou Cheng; Juergen Illnitzky; Thorsten Keil; Jiangtao Yu
Journal:  Heart Vessels       Date:  2018-03-22       Impact factor: 2.037

7.  Cerebrovascular events, bleeding complications and device related thrombi in atrial fibrillation patients with chronic kidney disease and left atrial appendage closure with the WATCHMAN™ device.

Authors:  Blerim Luani; Conrad Genz; Joerg Herold; Andreas Mitrasch; Julius Mitusch; Marcus Wiemer; Alexander Schmeißer; Rüdiger C Braun-Dullaeus; Thomas Rauwolf
Journal:  BMC Cardiovasc Disord       Date:  2019-05-15       Impact factor: 2.298

8.  Contemporary procedural trends of Watchman percutaneous left atrial appendage occlusion in the United States.

Authors:  Muhammad Bilal Munir; Muhammad Zia Khan; Douglas Darden; Deepak K Pasupula; Sudarshan Balla; Frederick T Han; Ryan Reeves; Jonathan C Hsu
Journal:  J Cardiovasc Electrophysiol       Date:  2020-11-11

9.  Effect of anticoagulation therapy in older patients with chronic kidney disease and atrial fibrillation: A meta-analysis.

Authors:  Wenfeng He; Hao Zhang; Wengen Zhu; Zhengbiao Xue
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

10.  Left atrial appendage closure in patients with chronic kidney disease: results from the German multicentre LAARGE registry.

Authors:  Christian Fastner; Johannes Brachmann; Thorsten Lewalter; Uwe Zeymer; Horst Sievert; Martin Borggrefe; Christoph A Nienaber; Christian Weiß; Sven T Pleger; Hüseyin Ince; Jens Maier; Stephan Achenbach; Holger H Sigusch; Matthias Hochadel; Steffen Schneider; Jochen Senges; Ibrahim Akin
Journal:  Clin Res Cardiol       Date:  2020-04-15       Impact factor: 5.460
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.